Helio Genomics Reveals Findings on New Colon Cancer Detection Method
Helio Genomics unveiled positive finds of its multimodal epigenetic sequencing assay (MESA) for colon cancer detection.
Read MorePosted by Andy Lundin | Jan 18, 2023 | Colorectal |
Helio Genomics unveiled positive finds of its multimodal epigenetic sequencing assay (MESA) for colon cancer detection.
Read MorePosted by Andy Lundin | Jan 17, 2023 | Molecular Diagnostics |
Optical genome mapping can outperform standard tests used for common blood cancers and help make better, more specific, diagnosis.
Read MorePosted by Andy Lundin | Jan 13, 2023 | Womens Health |
Researchers have identified biomarkers that could provide an early warning system for three common and dangerous pregnancy complications.
Read MorePosted by Andy Lundin | Jan 4, 2023 | Covid 19, Swabs |
Researchers discovered that testing for the presence of a single immune system molecule on nasal swabs can help detect stealthy viruses.
Read MorePosted by Andy Lundin | Jan 4, 2023 | Amplification Technologies |
A new CRISPR protein discovery holds potential for the development of new inexpensive and highly sensitive at-home diagnostic tests.
Read More